Andreas Mueller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andreas Mueller has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Peter Bartmann
Department of Neonatology, Childrens’s Hospital, University of Bonn, Bonn, Germany
4 shared publicationsArne Simon
Department of Pediatric Oncology and Hematology, Childrens’s Hospital, University of Saarland, Saarland, Germany
3 shared publicationsAxel Heep
Department of Neonatology, Children's Hospital, University of Bonn, Germany
3 shared publications- Axel Rainer Franz
Department of Neonatology, University Children’s Hospital, 72076 Tuebingen, Baden-Wuerttemberg, Germany
3 shared publications - Oliver Schildgen
Kliniken Der Stadt Köln gGmbH, Institut Für Pathologie, Ostmerheimer Str. 200, Cologne, Germany
3 shared publications Caspar Franzen
Department of Internal Medicine I, University of Regensburg, Regensburg, Germany
2 shared publications
Latest Publications
- Open Access
- 30 March 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 1-4
Familial tetrasomy 4q35.2 associated with congenital diaphragmatic hernia and unilateral renal agenesis: a case report
- 30 March 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 1-4
Open AccessFamilial tetrasomy 4q35.2 associated with congenital diaphragmatic hernia and unilateral renal agenesis: a case report
- 28 July 2015
- Published by IOS Press in Journal of Pediatric Infectious Diseases
- Vol. 08 (04) , 175-177
Successful treatment of an invasive Aspergillus flavus infection in a premature infant with liposomal amphotericin B and caspofungin
Aspergillosis is an uncommon diagnosis in neonates, especially if caused by Aspergillus flavus. Although amphotericin B remains the drug of choice for treatment of invasive aspergillosis, Aspergillus flavus has been reported as being resistant to amphotericin B. We present here a case of a 24-week gestational age preterm infant who developed skin and invasive intestinal Aspergillus flavus infection after laparotomy for necrotizing enterocolitis. Aspergillus flavus was first isolated from the smear of the umbilical stump at the third postoperative day. The initial response to antimycotic treatment with amphotericin B and caspofungin was not sufficient. Because of continued disseminated infection and multiple intra-abdominal abscesses with necrotic areas of the liver, a second surgical intervention was performed on the 24th day of life. Antimycotic therapy was continued for approximately 43 days so as to ensure clinical remission. No adverse events were observed. This case supports the importance of the combination of surgery and newer antimycotic drugs for the outcome of premature infants with invasive aspergillosis.
- 28 July 2015
- Published by IOS Press in Journal of Pediatric Infectious Diseases
- Vol. 08 (04) , 175-177
Successful treatment of an invasive Aspergillus flavus infection in a premature infant with liposomal amphotericin B and caspofungin
Aspergillosis is an uncommon diagnosis in neonates, especially if caused by Aspergillus flavus. Although amphotericin B remains the drug of choice for treatment of invasive aspergillosis, Aspergillus flavus has been reported as being resistant to amphotericin B. We present here a case of a 24-week gestational age preterm infant who developed skin and invasive intestinal Aspergillus flavus infection after laparotomy for necrotizing enterocolitis. Aspergillus flavus was first isolated from the smear of the umbilical stump at the third postoperative day. The initial response to antimycotic treatment with amphotericin B and caspofungin was not sufficient. Because of continued disseminated infection and multiple intra-abdominal abscesses with necrotic areas of the liver, a second surgical intervention was performed on the 24th day of life. Antimycotic therapy was continued for approximately 43 days so as to ensure clinical remission. No adverse events were observed. This case supports the importance of the combination of surgery and newer antimycotic drugs for the outcome of premature infants with invasive aspergillosis.
- 12 September 2009
- Published by Springer Nature in Archives of Virology
- Vol. 154 (10) , 1605-1608
Polyomaviruses KI and WU in children with respiratory tract infection
The polyomaviruses KI (KIPyV) and WU (WUPyV) have recently been discovered in specimens from patients with respiratory tract infections. To analyze the frequency and clinical impact in a cohort of pediatric patients in a German University Children’s Hospital. Nasopharyngeal aspirates or bronchoalveolar lavage specimens of 229 children with acute respiratory tract infection were screened for KIPyV and WUPyV using polymerase chain reaction-based methods. KIPyV was detected in 2 (0.9%) and WUPyV in 1 (0.4%) patients, without co-infections with other respiratory viruses but with co-detection of CMV, EBV and HHV 6 in one immunocompromised patient. Only a very small proportion (1.3%) of positive samples for KIPyV and WUPyV was documented in this study; the clinical relevance of these viruses remains unclear and requires further evaluation.
- 12 September 2009
- Published by Springer Nature in Archives of Virology
- Vol. 154 (10) , 1605-1608
Polyomaviruses KI and WU in children with respiratory tract infection
The polyomaviruses KI (KIPyV) and WU (WUPyV) have recently been discovered in specimens from patients with respiratory tract infections. To analyze the frequency and clinical impact in a cohort of pediatric patients in a German University Children’s Hospital. Nasopharyngeal aspirates or bronchoalveolar lavage specimens of 229 children with acute respiratory tract infection were screened for KIPyV and WUPyV using polymerase chain reaction-based methods. KIPyV was detected in 2 (0.9%) and WUPyV in 1 (0.4%) patients, without co-infections with other respiratory viruses but with co-detection of CMV, EBV and HHV 6 in one immunocompromised patient. Only a very small proportion (1.3%) of positive samples for KIPyV and WUPyV was documented in this study; the clinical relevance of these viruses remains unclear and requires further evaluation.
- 3 June 2009
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 37 (5) , 535-538
Prenatal diagnosis and postnatal management of meconium peritonitis
Background:Meconium peritonitis (MP) is a rare prenatal condition that leads to substantial neonatal morbidity and mortality.Patients and methods:All patients between 1998 and 2006 referred for prenatal diagnosis were retrospectively analyzed for diagnosis of MP. Prenatal ultrasound findings were compared with postnatal etiology, intraoperative findings, and postnatal outcome of the patients.Results:Antenatal MP was diagnosed in 14 fetuses between 18 and 38 weeks' gestation. The prenatal diagnosis of MP was confirmed by clinical and radiological findings in 8 (62%) of 13 infants born alive. All patients were delivered preterm between 33 and 36 weeks' gestation by cesarean section. Urgent neonatal surgery for treatment of bowel obstruction was required in all eight infants. Prenatal ultrasound diagnosis of bowel dilatation was the only variable found to be associated with the need for subsequent surgical intervention (P=0.02).Conclusions:Clinical outcome of MP diagnosed antenatally can be either mild or severe form. The underlying cause of severe MP is heterogeneous and neonatal surgery was always required.
- 3 June 2009
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 37 (5) , 535-538
Prenatal diagnosis and postnatal management of meconium peritonitis
Background:Meconium peritonitis (MP) is a rare prenatal condition that leads to substantial neonatal morbidity and mortality.Patients and methods:All patients between 1998 and 2006 referred for prenatal diagnosis were retrospectively analyzed for diagnosis of MP. Prenatal ultrasound findings were compared with postnatal etiology, intraoperative findings, and postnatal outcome of the patients.Results:Antenatal MP was diagnosed in 14 fetuses between 18 and 38 weeks' gestation. The prenatal diagnosis of MP was confirmed by clinical and radiological findings in 8 (62%) of 13 infants born alive. All patients were delivered preterm between 33 and 36 weeks' gestation by cesarean section. Urgent neonatal surgery for treatment of bowel obstruction was required in all eight infants. Prenatal ultrasound diagnosis of bowel dilatation was the only variable found to be associated with the need for subsequent surgical intervention (P=0.02).Conclusions:Clinical outcome of MP diagnosed antenatally can be either mild or severe form. The underlying cause of severe MP is heterogeneous and neonatal surgery was always required.
- 1 March 2009
- Published by Elsevier in Journal of Infection
- Vol. 58 (3) , 227-231
Low prevalence of human metapneumovirus and human bocavirus in adult immunocompromised high risk patients suspected to suffer from Pneumocystis pneumonia
- 1 March 2009
- Published by Elsevier in Journal of Infection
- Vol. 58 (3) , 227-231
Low prevalence of human metapneumovirus and human bocavirus in adult immunocompromised high risk patients suspected to suffer from Pneumocystis pneumonia
- 1 January 2009
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 2 (4) , 295-298
Unusual case of pericardial tamponade due to umbilical venous catheterization in a newborn with congenital chylothorax: Case report and review of the literature
Pericardial tamponade occurs rarely as severe complication of umbilical venous catheterization. We describe a preterm infant with congenital hydrothorax and mild hydrops fetalis who required umbilical venous catheterization for inotropic support and parenteral nutrition. The correct position of the UVC was verified by echocardiography and chest x-ray. The infant developed respiratory failure because of an increasing right sided pleural effusion at day 4 resulting in a mediastinal shift to the left side. During drainage of the pleural effusion the infant suddenly presented with decreasing blood pressure and subsequent bradycardia requiring resuscitation. Immediate transthoracic echocardiography revealed a cardiac tamponade due to pericardial effusion and pericardiocentesis was successfully performed promptly. The patient's conditions stabilized and he was discharged from hospital at 6 weeks postnatal age without apparent sequelae. Cardiac tamponade may occur despite correct position of the umbilical venous catheter. In our case the mediastinal shift presumably caused the atrial perforation by the catheter.
- 1 January 2009
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 2 (4) , 295-298
Unusual case of pericardial tamponade due to umbilical venous catheterization in a newborn with congenital chylothorax: Case report and review of the literature
Pericardial tamponade occurs rarely as severe complication of umbilical venous catheterization. We describe a preterm infant with congenital hydrothorax and mild hydrops fetalis who required umbilical venous catheterization for inotropic support and parenteral nutrition. The correct position of the UVC was verified by echocardiography and chest x-ray. The infant developed respiratory failure because of an increasing right sided pleural effusion at day 4 resulting in a mediastinal shift to the left side. During drainage of the pleural effusion the infant suddenly presented with decreasing blood pressure and subsequent bradycardia requiring resuscitation. Immediate transthoracic echocardiography revealed a cardiac tamponade due to pericardial effusion and pericardiocentesis was successfully performed promptly. The patient's conditions stabilized and he was discharged from hospital at 6 weeks postnatal age without apparent sequelae. Cardiac tamponade may occur despite correct position of the umbilical venous catheter. In our case the mediastinal shift presumably caused the atrial perforation by the catheter.
- 1 April 2008
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 27 (4) , 347-350
Detection of Astrovirus in Premature Infants With Necrotizing Enterocolitis
Background: Necrotizing enterocolitis (NEC) is a major cause of mortality and morbidity in very low birth weight infants (P < 0.001) but not for severity of illness, need for surgical intervention, or mortality. Conclusions: This study demonstrates that HAstV may be associated with the development of NEC in a subgroup of patients and provides further evidence for the important role of gastrointestinal viral infections in this most common gastrointestinal emergency in premature infants. HAstV should be included in microbiological examination of stool specimens in patients with NEC.
- 1 April 2008
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 27 (4) , 347-350
Detection of Astrovirus in Premature Infants With Necrotizing Enterocolitis
Background: Necrotizing enterocolitis (NEC) is a major cause of mortality and morbidity in very low birth weight infants (P < 0.001) but not for severity of illness, need for surgical intervention, or mortality. Conclusions: This study demonstrates that HAstV may be associated with the development of NEC in a subgroup of patients and provides further evidence for the important role of gastrointestinal viral infections in this most common gastrointestinal emergency in premature infants. HAstV should be included in microbiological examination of stool specimens in patients with NEC.
- 31 December 2007
- Published by Springer Nature in Journal of Perinatology
- Vol. 28 (1) , 74-76
Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant
Cytomegalovirus (CMV) infection is the most important congenital viral infection. Intravenous (i.v.) Ganciclovir (GCV) improved outcome in term infants with symptomatic congenital CMV infection. We present data on oral valganciclovir (VGCV) in an extremely low birth weight infant. A male preterm infant was delivered at 28 weeks of gestation because of abnormal fetal perfusion with severe intrauterine growth retardation. The infant developed hepatitis and a severe thrombocytopenia. Serology revealed a positive CMV IgM in maternal serum 3 days after delivery and CMV DNA was detected in plasma and urine samples of the infants. Treatment with i.v. GCV was started at day 4 of life for 35 days and continued with oral VGCV for further 6 weeks. Plasma GCV levels were 1.68 ng ml−1 (peak) and 0.92 ng ml−1 (trough) on day 10 of oral treatment. Clinical signs resolved and virus load decreased slowly during therapy. At discharge brain stem-evoked audiometry was normal. Oral treatment with VGCV in an extremely low birth weight preterm infant with congenital CMV infection resulted in adequate GCV plasma levels, reduced effectively the CMV viral load and was well tolerated without apparent adverse effects.
- 31 December 2007
- Published by Springer Nature in Journal of Perinatology
- Vol. 28 (1) , 74-76
Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant
Cytomegalovirus (CMV) infection is the most important congenital viral infection. Intravenous (i.v.) Ganciclovir (GCV) improved outcome in term infants with symptomatic congenital CMV infection. We present data on oral valganciclovir (VGCV) in an extremely low birth weight infant. A male preterm infant was delivered at 28 weeks of gestation because of abnormal fetal perfusion with severe intrauterine growth retardation. The infant developed hepatitis and a severe thrombocytopenia. Serology revealed a positive CMV IgM in maternal serum 3 days after delivery and CMV DNA was detected in plasma and urine samples of the infants. Treatment with i.v. GCV was started at day 4 of life for 35 days and continued with oral VGCV for further 6 weeks. Plasma GCV levels were 1.68 ng ml−1 (peak) and 0.92 ng ml−1 (trough) on day 10 of oral treatment. Clinical signs resolved and virus load decreased slowly during therapy. At discharge brain stem-evoked audiometry was normal. Oral treatment with VGCV in an extremely low birth weight preterm infant with congenital CMV infection resulted in adequate GCV plasma levels, reduced effectively the CMV viral load and was well tolerated without apparent adverse effects.
- 1 September 2005
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 24 (9) , 778-781
Detection of Polyomavirus BK and JC in Children With Kidney Diseases and Renal Transplant Recipients
Reactivation of polyomavirus is a known reason for severe renal dysfunction in adult renal transplant recipients. Testing for polyomavirus DNA in plasma has been described as a sensitive and specific method to discover viral nephropathy in adult patients. We were now interested in polyomavirus status in a pediatric patient setting. Plasma and urine samples were obtained from 80 children including 38 children after renal transplantation (group 1), 7 children with different kidney diseases receiving immunosuppressive treatment (group 2) and 35 children with different kidney diseases not receiving immunosuppressive treatment (group 3). A nested polymerase chain reaction method was used for amplification of polyomavirus DNA fragments. Differentiation between JC and BK virus was done by digestion with restriction endonucleases. Polyomavirus DNA was detected in the urine sample of 19 of 38 (50%) renal transplant recipients (group 1), of 1 of 7 (14%) patients from group 2 and in none of the 35 patients of group 3. Plasma samples from 3 (8%) of group 1 patients and from 1 child each of group 2 (14%) and group 3 (3%) were tested positive for polyomavirus DNA. Urinary polyomavirus excretion seems to be more frequent in pediatric patients with kidney diseases receiving immunosuppressive treatment and after renal transplantation than in children with various kidney diseases without immunosuppressive treatment.
- 1 September 2005
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 24 (9) , 778-781
Detection of Polyomavirus BK and JC in Children With Kidney Diseases and Renal Transplant Recipients
Reactivation of polyomavirus is a known reason for severe renal dysfunction in adult renal transplant recipients. Testing for polyomavirus DNA in plasma has been described as a sensitive and specific method to discover viral nephropathy in adult patients. We were now interested in polyomavirus status in a pediatric patient setting. Plasma and urine samples were obtained from 80 children including 38 children after renal transplantation (group 1), 7 children with different kidney diseases receiving immunosuppressive treatment (group 2) and 35 children with different kidney diseases not receiving immunosuppressive treatment (group 3). A nested polymerase chain reaction method was used for amplification of polyomavirus DNA fragments. Differentiation between JC and BK virus was done by digestion with restriction endonucleases. Polyomavirus DNA was detected in the urine sample of 19 of 38 (50%) renal transplant recipients (group 1), of 1 of 7 (14%) patients from group 2 and in none of the 35 patients of group 3. Plasma samples from 3 (8%) of group 1 patients and from 1 child each of group 2 (14%) and group 3 (3%) were tested positive for polyomavirus DNA. Urinary polyomavirus excretion seems to be more frequent in pediatric patients with kidney diseases receiving immunosuppressive treatment and after renal transplantation than in children with various kidney diseases without immunosuppressive treatment.